News for Ariad Pharmaceuticals, Inc. - Google FinanceNews for Ariad Pharmaceuticals, Inc. - Google FinanceAriad Pharmaceuticals Inc (ARIA) holdings reduced by Franklin Resources Inc- August 8, 2008 Ariad Pharmaceuticals Inc (ARIA) holdings reduced by Franklin Resources Inc Mffais.com - Aug 8, 2008 LONG BEACH ( Mffais . com ) - Franklin Resources Inc sold - 231,800 ( - 23.89 % ) of their shares in Ariad Pharmaceuticals Inc ( ARIA ) , bringing their current holdings to 738,300 shares as ...http://www.mffais.com/newsarticles/2008-08-07/2348723-125752.html Ariad chief operating officer resigns- August 7, 2008 Ariad chief operating officer resigns Forbes - Aug 7, 2008 AP 08.07 . 08 , 9 : 52 AM ETDrug developer Ariad Pharmaceuticals Inc . said Thursday that Senior Vice President and Chief Operating Officer Richard W . Pascoe resigned to take a position elsewhere.Pascoe ...http://www.forbes.com/feeds/ap/2008/08/07/ap5299797.html Ariad's 2Q loss widens on higher costs- August 7, 2008 Ariad's 2Q loss widens on higher costs Forbes - Aug 7, 2008 AP 08.07 . 08 , 9 : 49 AM ETDrug developer Ariad Pharmaceuticals Inc . said Thursday its second - quarter loss widened slightly on higher research and development costs.The company lost $17.3 ... ARIAD Reports Second Quarter 2008 Financial Results - Business Wire (press release) ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Endometrial Cancer - Business Wire (press release)http://www.forbes.com/feeds/ap/2008/08/07/ap5299772.html UPDATE 1-Ariad Q2 loss narrower than expected; COO resigns- August 7, 2008 UPDATE 1-Ariad Q2 loss narrower than expected; COO resigns Reuters - Aug 7, 2008 Aug 7 ( Reuters ) - Ariad Pharmaceuticals Inc ( ARIA.O : Quote , Profile , Research , Stock Buzz ) posted a narrower - than - expected quarterly loss , helped by milestone payments from its partner ...http://www.reuters.com/article/rbssHealthcareNews/idUSBNG16152120080807 Ariad to receive $2.5 million from partner Merck- August 6, 2008 Ariad to receive $2.5 million from partner Merck CNNMoney.com - Aug 6, 2008 NEW YORK ( Associated Press ) - Ariad Pharmaceuticals Inc . said Wednesday it will receive a $2.5 million payment from partner Merck & Co . for moving a cancer drug into midstage clinical trials.The ... Ariad earns $2.5M from Merck - Bizjournals.com ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Endometrial Cancer - FOXBusinesshttp://money.cnn.com/news/newsfeeds/articles/apwire/a0a4d696267d0052c3e21bdeb490e9c6.htm Ariad Pharmaceuticals Inc (ARIA) holdings reduced by Vanguard Group Inc- August 6, 2008 Ariad Pharmaceuticals Inc (ARIA) holdings reduced by Vanguard Group Inc Mffais.com - Aug 6, 2008 LONG BEACH ( Mffais . com ) - Vanguard Group Inc sold - 888,058 ( - 99.69 % ) of their shares in Ariad Pharmaceuticals Inc ( ARIA ) , bringing their current holdings to 2,751 shares as shown ...http://www.mffais.com/newsarticles/2008-08-05/2348723-123749.html Ariad Starts Phase II Study for Breast Cancer- August 5, 2008 Ariad Starts Phase II Study for Breast Cancer FDA news (subscription) - Aug 5, 2008 Ariad Pharmaceuticals has initiated a Phase II clinical trial to examine oral deforolimus , its investigational mTOR inhibitor , in patients with advanced breast cancer.The multicenter , single ...http://fdanews.com/newsletter/article?issueId=11832&articleId=109180 |